Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 08-07-2003, 03:14 AM   #1
Paul C.
Posts: n/a
The cross-link below provides recent reported finds entitled "Trastuzumab [Herceptin] and Vinorelbine [Navelbine] as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes Analysis of Serum Tumor Markers as Predictive Factors and Cardiac Surveillance Algorithm."

These findings are reported in the August 1 2003 edition of the Journal of Clinical Oncology (Vol 21 Issue 15 pp. 2889-2895). The JCO is a publication of the American Society of Clinical Oncology (ASCO).
  Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump

All times are GMT -7. The time now is 04:41 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter